DK0471618T3 - Calcitonin-holdig emulsion til nasal administrering - Google Patents

Calcitonin-holdig emulsion til nasal administrering

Info

Publication number
DK0471618T3
DK0471618T3 DK91402231.4T DK91402231T DK0471618T3 DK 0471618 T3 DK0471618 T3 DK 0471618T3 DK 91402231 T DK91402231 T DK 91402231T DK 0471618 T3 DK0471618 T3 DK 0471618T3
Authority
DK
Denmark
Prior art keywords
calcitonin
nasal administration
containing emulsion
preparations
azacyclopentan
Prior art date
Application number
DK91402231.4T
Other languages
Danish (da)
English (en)
Inventor
Nakayuki Yamamoto
Michihiko Sugimoto
Hideo Sakakibara
Masaru Saita
Yuji Shimozono
Takafumi Manako
Original Assignee
Hisamitsu Pharmaceutical Co
Asahi Chemical Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co, Asahi Chemical Ind filed Critical Hisamitsu Pharmaceutical Co
Application granted granted Critical
Publication of DK0471618T3 publication Critical patent/DK0471618T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
DK91402231.4T 1990-08-16 1991-08-12 Calcitonin-holdig emulsion til nasal administrering DK0471618T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2215044A JPH078806B2 (ja) 1990-08-16 1990-08-16 カルシトニン類含有経鼻投与用乳剤

Publications (1)

Publication Number Publication Date
DK0471618T3 true DK0471618T3 (da) 1993-11-29

Family

ID=16665828

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91402231.4T DK0471618T3 (da) 1990-08-16 1991-08-12 Calcitonin-holdig emulsion til nasal administrering

Country Status (13)

Country Link
US (1) US5281580A (ja)
EP (1) EP0471618B1 (ja)
JP (1) JPH078806B2 (ja)
KR (1) KR950000770B1 (ja)
AT (1) ATE95063T1 (ja)
AU (1) AU629758B2 (ja)
CA (1) CA2047903C (ja)
DE (1) DE69100436T2 (ja)
DK (1) DK0471618T3 (ja)
ES (1) ES2060329T3 (ja)
IE (1) IE65630B1 (ja)
NZ (1) NZ239166A (ja)
PT (1) PT98692B (ja)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3090353B2 (ja) * 1991-09-17 2000-09-18 旭化成工業株式会社 パラチロイドホルモン類含有経鼻投与用乳剤
IT1251685B (it) * 1991-10-11 1995-05-19 Isf Spa Composizioni farmaceutiche contenenti una calcitonina
US5948825A (en) * 1993-04-19 1999-09-07 Institute For Advanced Skin Research Inc. Microemulsion preparation containing a slightly absorbable substance
EP0726075A1 (en) * 1995-02-08 1996-08-14 Therapicon Srl Pharmaceutical non-inorganic saline solutions for endonasal administration
DE29723959U1 (de) * 1997-07-22 1999-07-22 Zellner Nasenspray-Flüssigkeit
TWI243687B (en) * 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
JP2000247911A (ja) * 1999-02-26 2000-09-12 Hisamitsu Pharmaceut Co Inc 大腸用吸収促進剤
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
WO2001056594A1 (en) 2000-02-04 2001-08-09 Unigene Laboratories, Inc. Nasal calcitonin formulations
US7244703B2 (en) * 2001-06-22 2007-07-17 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for peptide treatment
US7812120B2 (en) 2003-03-21 2010-10-12 Par Pharmaceutical, Inc. Nasal calcitonin formulations containing chlorobutanol
ATE474591T1 (de) 2003-12-08 2010-08-15 Cpex Pharmaceuticals Inc Pharmazeutische zusammensetzungen und verfahren für die insulinbehandlung
GB2423711B (en) * 2005-10-24 2007-02-14 Fortune Apex Dev Ltd Method for preparing a pharmaceutical composition with enhanced mucoadhesion
WO2008007214A2 (en) * 2006-07-07 2008-01-17 Avestha Gengraine Technologies Pvt. Ltd. Glycyrrhiza glabra plant extracts for treating osteoporosis and the extraction process thereof
ES2394525T3 (es) 2006-09-27 2013-02-01 Asahi Kasei Pharma Corporation Calcitoninas para la prevención de la aparición de la distrofia simpática refleja tras un accidente cerebrovascular
KR101686271B1 (ko) 2009-11-18 2016-12-13 아사히 가세이 파마 가부시키가이샤 인간 변형성 슬관절증의 예방제 및/또는 치료제 및/또는 악화 억제제
US20190210394A1 (en) * 2018-01-05 2019-07-11 Beatrice A. Darby Reading staff book system

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2212062A (en) * 1938-04-16 1940-08-20 Harry O Duerr Waste destructor and garbage reclamation unit
GB2127689B (en) * 1982-10-05 1986-07-09 Sandoz Ltd Calcitonin inhalation compositions
AU572815B2 (en) * 1982-12-29 1988-05-19 Armour Pharmaceutical Company Pharmaceutical calcitonin compositions for intranasal application
JPS61267528A (ja) * 1984-11-26 1986-11-27 Yamanouchi Pharmaceut Co Ltd 吸収促進剤を含有するカルシトニン経鼻剤
US4690852A (en) * 1985-06-11 1987-09-01 Paul Gach Foil for stained glass assembly
EP0234745B1 (en) * 1986-01-29 1991-06-12 Dyson Refractories Limited Catalysts
JPH0643390B2 (ja) * 1986-04-08 1994-06-08 久光製薬株式会社 アザシクロアルカン誘導体
ES2061688T3 (es) * 1987-11-13 1994-12-16 Smithkline Beecham Farma Composiciones farmaceuticas que comprenden una calcitonina y un glicirricinato como mejorador de la absorcion.
US5026825A (en) * 1988-09-08 1991-06-25 Rhone-Poulenc Rorer Pharmaceuticals Inc. Intranasal calcitonin formulations
JPH0669956B2 (ja) * 1988-09-30 1994-09-07 旭化成工業株式会社 ポリペプタイド類の吸着防止剤

Also Published As

Publication number Publication date
US5281580A (en) 1994-01-25
DE69100436D1 (de) 1993-11-04
EP0471618A1 (en) 1992-02-19
JPH0499729A (ja) 1992-03-31
KR920003991A (ko) 1992-03-27
NZ239166A (en) 1992-11-25
ATE95063T1 (de) 1993-10-15
IE65630B1 (en) 1995-11-01
EP0471618B1 (en) 1993-09-29
KR950000770B1 (ko) 1995-02-02
DE69100436T2 (de) 1994-01-20
IE912614A1 (en) 1992-02-26
PT98692B (pt) 1999-01-29
JPH078806B2 (ja) 1995-02-01
CA2047903A1 (en) 1992-02-17
AU629758B2 (en) 1992-10-08
AU8244591A (en) 1992-02-20
PT98692A (pt) 1992-07-31
CA2047903C (en) 1995-12-05
ES2060329T3 (es) 1994-11-16

Similar Documents

Publication Publication Date Title
DK0471618T3 (da) Calcitonin-holdig emulsion til nasal administrering
DK358384A (da) Farmaceutiske midler til bekaempelse af diabetes mellitus
DK0552256T3 (da) Fremgangsmåde til at behandle eller forebygge type 1 diabetes ved peroral indgivelse af insulin
ES2117642T3 (es) Preparado farmaceutico que contiene n-glicofuroles y n-etilen glicoles.
BR9408343A (pt) Derivados 5-(2-imidazolinil amino) benzimidazol sua preparação e seu uso como agonistas alfa-2 adrenoceptor
DZ1067A1 (fr) Nouvelles préparations pharmaceutiques à emission prolongée.
KR890003369A (ko) 약제학적 제제
DE59010810D1 (de) Arzneimittel enthaltend als Wirkstoff R-alpha-Liponsäure oder S-alpha-Liponsäure
NO166448C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidindioner.
MY102565A (en) Novel derivatives of guanine
ZA874812B (en) Drug
ATE191719T1 (de) Analoge des calcitonin aus lachs, ihre herstellung und ihre verwendung als medizin und als analytische reagentien
ATE168562T1 (de) Parathyroidhormon enthaltene emulsion zur nasalen verabreichung
DK0490549T3 (da) Stabilisering af calcitonin-holdige farmaceutiske præparater
SE8600632D0 (sv) Novel pharmaceutical composition
DE69333723D1 (de) Pharmazeutische zubereitung auf der basis von rhamnolipid gegen dermatologische erkrankungen
KR900009606A (ko) 불소-함유 2-니트로 이미다졸 유도체 및 그를 함유하는 방사선 증감제
KR910004191A (ko) 신질환치료제
LV10267A (lv) Savienojums arstniecibas lidzeklis panemiens savienojuma iegusanai
RU2209064C2 (ru) Новое применение в медицинских целях
EA199900226A1 (ru) Фармацевтические композиции для лечения вирусных заболеваний
KR900701278A (ko) 바이러스 감염 치료용 담즙산
SE8204670D0 (sv) Ny forening med antiulcerogen aktivitet, forfarande for dess framstellning och farmaceutisk beredning innehallande densamma
EA199800177A1 (ru) Способ снижения количества экзогенного инсулина, вводимого пациенту с инсулиннезависимым сахарным диабетом
KR900014308A (ko) 비스펜에탄올아민